| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microtubule binding | CEP290 KIF20B KIF7 CCDC88A HOOK3 CDK5RAP2 MACF1 CEP295 ARHGEF2 KIF17 | 1.48e-05 | 308 | 118 | 10 | GO:0008017 |
| GeneOntologyMolecularFunction | small GTPase binding | TNPO1 ROCK2 DOCK3 SIKE1 IQGAP1 MICALL1 GCC2 RNF41 ARHGEF2 GOLGA4 | 2.11e-05 | 321 | 118 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | tubulin binding | TPR CEP290 KIF20B KIF7 CCDC88A HOOK3 CDK5RAP2 MACF1 CEP295 ARHGEF2 KIF17 | 4.72e-05 | 428 | 118 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 5.27e-05 | 35 | 118 | 4 | GO:0051019 | |
| GeneOntologyMolecularFunction | GTPase binding | TNPO1 ROCK2 DOCK3 SIKE1 IQGAP1 MICALL1 GCC2 RNF41 ARHGEF2 GOLGA4 | 5.56e-05 | 360 | 118 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor binding | 1.29e-04 | 17 | 118 | 3 | GO:0005172 | |
| GeneOntologyMolecularFunction | protein kinase binding | TPR ATF7 SIKE1 ANGPT1 ANGPT2 E2F1 NBEA TRIM34 UFL1 IQGAP1 SLC12A5 CCDC88A CDK5RAP2 RNF41 NBR1 | 1.96e-04 | 873 | 118 | 15 | GO:0019901 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ROCK2 TPR SYNE1 SPTBN2 CEP290 KIF20B IQGAP1 KIF7 BLOC1S6 CCDC88A HOOK3 CDK5RAP2 MACF1 CEP295 ARHGEF2 CROCC KIF17 | 2.50e-04 | 1099 | 118 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | kinase binding | TPR ATF7 SIKE1 ANGPT1 ANGPT2 E2F1 NBEA TRIM34 UFL1 IQGAP1 SLC12A5 CCDC88A CDK5RAP2 RNF41 NBR1 | 5.90e-04 | 969 | 118 | 15 | GO:0019900 |
| GeneOntologyBiologicalProcess | microtubule-based process | ROCK2 TPR CEP290 APOB DZIP1 CNTROB KIF20B KIF7 FSIP2 BLOC1S6 CCDC88A HOOK3 GCC2 CEP250 NAV1 CDK5RAP2 MACF1 CEP295 CFAP57 ARHGEF2 CROCC SPAG17 KIF17 | 2.79e-08 | 1058 | 118 | 23 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ROCK2 TPR CEP290 DZIP1 CNTROB FSIP2 CCDC88A HOOK3 GCC2 CEP250 NAV1 CDK5RAP2 CEP295 CFAP57 ARHGEF2 CROCC SPAG17 | 7.31e-07 | 720 | 118 | 17 | GO:0000226 |
| GeneOntologyBiologicalProcess | cilium organization | SYNE1 CEP290 DZIP1 CNTROB CEP164 FSIP2 BLOC1S6 CCDC88A CEP250 CFAP57 CROCC SPAG17 KIF17 | 3.44e-06 | 476 | 118 | 13 | GO:0044782 |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | TPR SYNE1 SPTBN2 DZIP1 CNTROB CCDC88A CDK5RAP2 CEP295 ARHGEF2 CROCC | 4.86e-06 | 280 | 118 | 10 | GO:1902115 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to cilium | 6.28e-06 | 7 | 118 | 3 | GO:1903566 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 8.93e-06 | 179 | 118 | 8 | GO:0031023 | |
| GeneOntologyBiologicalProcess | cilium assembly | SYNE1 CEP290 DZIP1 CNTROB CEP164 FSIP2 BLOC1S6 CCDC88A CEP250 CFAP57 CROCC SPAG17 | 9.28e-06 | 444 | 118 | 12 | GO:0060271 |
| GeneOntologyBiologicalProcess | organelle assembly | TPR SYNE1 SPTBN2 CEP290 FASTKD2 DZIP1 CNTROB CEP164 FSIP2 BLOC1S6 CCDC88A CEP250 CDK5RAP2 CEP295 CFAP57 ARHGEF2 CROCC SPAG17 VPS13B | 2.41e-05 | 1138 | 118 | 19 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of protein localization to cilium | 2.91e-05 | 11 | 118 | 3 | GO:1903564 | |
| GeneOntologyBiologicalProcess | slow endocytic recycling | 3.25e-05 | 2 | 118 | 2 | GO:0032458 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | TNPO1 ROCK2 TPR ANGPT1 SYNE1 NBEA DZIP1 TEX15 KIF20B MICALL1 FSIP2 VPS13D CCDC88A HOOK3 GCC2 CEP250 MACF1 CROCC | 4.73e-05 | 1091 | 118 | 18 | GO:0033365 |
| GeneOntologyBiologicalProcess | intracellular transport | TNPO1 DDX19B TPR CCHCR1 ANGPT1 SYNE1 CEP290 KIF20B MICALL1 BLOC1S6 VPS13D CCDC88A HOOK3 GCC2 SNX8 ARHGEF2 SPAG17 KIF17 VPS13B DOP1B CREB3L2 | 1.08e-04 | 1496 | 118 | 21 | GO:0046907 |
| GeneOntologyBiologicalProcess | canonical NF-kappaB signal transduction | 1.19e-04 | 330 | 118 | 9 | GO:0007249 | |
| GeneOntologyBiologicalProcess | neuron projection development | ROCK2 DHX36 PLEKHG4 SYNE1 CDH23 KIF20B MFN1 IQGAP1 SLC12A5 MICALL1 ARHGAP4 BLOC1S6 CCDC88A TENM3 MACF1 FLOT1 VPS13B GOLGA4 CREB3L2 | 1.23e-04 | 1285 | 118 | 19 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of protein localization | ROCK2 TPR ANGPT1 CEP290 NBEA TRIM34 UFL1 DZIP1 TEX15 IDUA KIF20B IQGAP1 CCDC88A GCC2 CEP250 CEP295 CROCC | 1.50e-04 | 1087 | 118 | 17 | GO:0032880 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | ROCK2 TPR DHX36 ANGPT1 CEP290 NBEA TRIM34 UFL1 DZIP1 TEX15 IDUA KIF20B IQGAP1 CCDC88A GCC2 CEP250 CEP295 CROCC | 1.79e-04 | 1212 | 118 | 18 | GO:0060341 |
| GeneOntologyBiologicalProcess | nuclear matrix organization | 1.93e-04 | 4 | 118 | 2 | GO:0043578 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ROCK2 TPR DHX36 EXOSC10 SYNE1 SPTBN2 UFL1 DZIP1 CNTROB KIF20B MFN1 VPS13D CCDC88A VAMP1 CDK5RAP2 RNF41 CEP295 ARHGEF2 CROCC | 2.15e-04 | 1342 | 118 | 19 | GO:0033043 |
| GeneOntologyBiologicalProcess | neuron development | ROCK2 DHX36 PLEKHG4 SYNE1 CEP290 CDH23 KIF20B MFN1 IQGAP1 SLC12A5 MICALL1 ARHGAP4 BLOC1S6 CCDC88A TENM3 MACF1 FLOT1 VPS13B GOLGA4 CREB3L2 | 2.29e-04 | 1463 | 118 | 20 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | ROCK2 TPR DHX36 ANGPT1 SYNE1 UFL1 DZIP1 MFN1 IQGAP1 VPS13D CCDC88A TENM3 CDK5RAP2 MACF1 CEP295 CROCC FLOT1 GOLGA4 CREB3L2 | 2.69e-04 | 1366 | 118 | 19 | GO:0051130 |
| GeneOntologyBiologicalProcess | regulation of canonical NF-kappaB signal transduction | 3.20e-04 | 298 | 118 | 8 | GO:0043122 | |
| GeneOntologyBiologicalProcess | Tie signaling pathway | 3.21e-04 | 5 | 118 | 2 | GO:0048014 | |
| GeneOntologyBiologicalProcess | centrosome cycle | 3.65e-04 | 164 | 118 | 6 | GO:0007098 | |
| GeneOntologyBiologicalProcess | regulation of establishment of cell polarity | 3.83e-04 | 25 | 118 | 3 | GO:2000114 | |
| GeneOntologyBiologicalProcess | regulation of cilium assembly | 3.92e-04 | 108 | 118 | 5 | GO:1902017 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | ROCK2 TPR DHX36 UFL1 DZIP1 MFN1 VPS13D CCDC88A CDK5RAP2 CEP295 CROCC | 4.59e-04 | 574 | 118 | 11 | GO:0010638 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | SYNE1 CEP290 DZIP1 CNTROB CEP164 FSIP2 BLOC1S6 CCDC88A CEP250 CFAP57 CROCC SPAG17 | 4.62e-04 | 670 | 118 | 12 | GO:0120031 |
| GeneOntologyBiologicalProcess | ciliary basal body organization | 4.80e-04 | 6 | 118 | 2 | GO:0032053 | |
| GeneOntologyBiologicalProcess | positive regulation of centrosome duplication | 4.80e-04 | 6 | 118 | 2 | GO:0010825 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | DHX36 DZIP1 MFN1 IQGAP1 CCDC88A TENM3 MACF1 CROCC GOLGA4 CREB3L2 | 5.49e-04 | 494 | 118 | 10 | GO:0031346 |
| GeneOntologyBiologicalProcess | cell projection assembly | SYNE1 CEP290 DZIP1 CNTROB CEP164 FSIP2 BLOC1S6 CCDC88A CEP250 CFAP57 CROCC SPAG17 | 5.62e-04 | 685 | 118 | 12 | GO:0030031 |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 6.12e-04 | 119 | 118 | 5 | GO:0006892 | |
| GeneOntologyBiologicalProcess | regulation of establishment or maintenance of cell polarity | 6.62e-04 | 30 | 118 | 3 | GO:0032878 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 7.00e-04 | 257 | 118 | 7 | GO:0007163 | |
| GeneOntologyCellularComponent | centriole | CCHCR1 CEP290 DZIP1 CNTROB CEP164 CCDC88A CEP250 CEP295 CROCC | 7.19e-07 | 172 | 121 | 9 | GO:0005814 |
| GeneOntologyCellularComponent | microtubule organizing center | ROCK2 CCHCR1 CEP290 CDH23 E2F1 DZIP1 CNTROB KIF20B CEP164 KIF7 CCDC88A HOOK3 CEP112 CEP250 CDK5RAP2 CEP295 CROCC FLOT1 KIF17 | 1.37e-06 | 919 | 121 | 19 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | ROCK2 CEP290 CDH23 E2F1 DZIP1 CNTROB KIF20B CEP164 CCDC88A HOOK3 CEP112 CEP250 CDK5RAP2 CEP295 CROCC FLOT1 | 9.55e-06 | 770 | 121 | 16 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule | KIF20B IQGAP1 KIF7 ARHGAP4 HOOK3 NAV1 CDK5RAP2 MACF1 CEP295 ARHGEF2 SPAG17 KIF17 | 6.28e-05 | 533 | 121 | 12 | GO:0005874 |
| GeneOntologyCellularComponent | trans-Golgi network | 7.39e-05 | 306 | 121 | 9 | GO:0005802 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 9.01e-05 | 78 | 121 | 5 | GO:0001917 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT78 KRT33A KIF20B IQGAP1 KIF7 ARHGAP4 BLOC1S6 HOOK3 NAV1 CDK5RAP2 MACF1 CEP295 ARHGEF2 SPAG17 KIF17 | 2.18e-04 | 899 | 121 | 15 | GO:0099513 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | NBEA MICALL1 SLC30A5 GCC2 CHPF2 GOLGA1 VPS13B GOLGA4 ECE2 DOP1B | 2.57e-04 | 443 | 121 | 10 | GO:0098791 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT78 KRT33A SYNE1 KIF20B IQGAP1 KIF7 ARHGAP4 BLOC1S6 HOOK3 NAV1 CDK5RAP2 MACF1 CEP295 ARHGEF2 SPAG17 KIF17 NBR1 | 4.49e-04 | 1179 | 121 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT78 KRT33A SYNE1 KIF20B IQGAP1 KIF7 ARHGAP4 BLOC1S6 HOOK3 NAV1 CDK5RAP2 MACF1 CEP295 ARHGEF2 SPAG17 KIF17 NBR1 | 4.85e-04 | 1187 | 121 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | ciliary basal body | 9.65e-04 | 195 | 121 | 6 | GO:0036064 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.42e-03 | 287 | 121 | 7 | GO:0035770 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 1.45e-03 | 10 | 121 | 2 | GO:0097539 | |
| Domain | Prefoldin | 3.73e-07 | 72 | 119 | 7 | IPR009053 | |
| Domain | - | 2.93e-05 | 10 | 119 | 3 | 1.10.220.60 | |
| Domain | Grip | 4.01e-05 | 11 | 119 | 3 | SM00755 | |
| Domain | GRIP | 4.01e-05 | 11 | 119 | 3 | PF01465 | |
| Domain | GRIP_dom | 5.32e-05 | 12 | 119 | 3 | IPR000237 | |
| Domain | GRIP | 5.32e-05 | 12 | 119 | 3 | PS50913 | |
| Domain | CH | 5.87e-05 | 65 | 119 | 5 | SM00033 | |
| Domain | CH | 8.39e-05 | 70 | 119 | 5 | PF00307 | |
| Domain | - | 8.98e-05 | 71 | 119 | 5 | 1.10.418.10 | |
| Domain | CH | 1.03e-04 | 73 | 119 | 5 | PS50021 | |
| Domain | CH-domain | 1.17e-04 | 75 | 119 | 5 | IPR001715 | |
| Domain | SHR-BD | 2.40e-04 | 4 | 119 | 2 | IPR009543 | |
| Domain | LRRC37AB_C | 2.40e-04 | 4 | 119 | 2 | IPR029423 | |
| Domain | LRRC37AB_C | 2.40e-04 | 4 | 119 | 2 | PF14914 | |
| Domain | VPS13_C | 2.40e-04 | 4 | 119 | 2 | PF16909 | |
| Domain | LRRC37_N | 2.40e-04 | 4 | 119 | 2 | IPR032754 | |
| Domain | VPS13_C | 2.40e-04 | 4 | 119 | 2 | IPR031645 | |
| Domain | LRRC37 | 2.40e-04 | 4 | 119 | 2 | PF15779 | |
| Domain | SHR-BD | 2.40e-04 | 4 | 119 | 2 | PF06650 | |
| Domain | LRRC37A/B-like | 2.40e-04 | 4 | 119 | 2 | IPR015753 | |
| Domain | BZIP_BASIC | 3.61e-04 | 53 | 119 | 4 | PS00036 | |
| Domain | bZIP | 3.87e-04 | 54 | 119 | 4 | IPR004827 | |
| Domain | Spectrin | 4.07e-04 | 23 | 119 | 3 | PF00435 | |
| Domain | ACTININ_2 | 4.07e-04 | 23 | 119 | 3 | PS00020 | |
| Domain | ACTININ_1 | 4.07e-04 | 23 | 119 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.07e-04 | 23 | 119 | 3 | IPR001589 | |
| Domain | HOOK | 5.94e-04 | 6 | 119 | 2 | PF05622 | |
| Domain | Hook-related_fam | 5.94e-04 | 6 | 119 | 2 | IPR008636 | |
| Domain | PH | 6.66e-04 | 229 | 119 | 7 | PF00169 | |
| Domain | ZF_DAG_PE_1 | 7.41e-04 | 64 | 119 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 7.41e-04 | 64 | 119 | 4 | PS50081 | |
| Domain | C1 | 7.86e-04 | 65 | 119 | 4 | SM00109 | |
| Domain | Spectrin_repeat | 8.17e-04 | 29 | 119 | 3 | IPR002017 | |
| Domain | Peptidase_M13_C | 8.28e-04 | 7 | 119 | 2 | IPR018497 | |
| Domain | Peptidase_M13 | 8.28e-04 | 7 | 119 | 2 | IPR000718 | |
| Domain | Peptidase_M13_N | 8.28e-04 | 7 | 119 | 2 | PF05649 | |
| Domain | Peptidase_M13_N | 8.28e-04 | 7 | 119 | 2 | IPR008753 | |
| Domain | Peptidase_M13 | 8.28e-04 | 7 | 119 | 2 | PF01431 | |
| Domain | PE/DAG-bd | 8.33e-04 | 66 | 119 | 4 | IPR002219 | |
| Domain | SPEC | 1.09e-03 | 32 | 119 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.09e-03 | 32 | 119 | 3 | IPR018159 | |
| Domain | Chorein_N | 1.10e-03 | 8 | 119 | 2 | PF12624 | |
| Domain | VPS13_N | 1.10e-03 | 8 | 119 | 2 | IPR026854 | |
| Domain | TF_DNA-bd | 1.67e-03 | 37 | 119 | 3 | IPR008917 | |
| Domain | PH | 2.04e-03 | 278 | 119 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 2.08e-03 | 279 | 119 | 7 | PS50003 | |
| Domain | PH_domain | 2.12e-03 | 280 | 119 | 7 | IPR001849 | |
| Domain | Kinesin_motor_CS | 2.25e-03 | 41 | 119 | 3 | IPR019821 | |
| Domain | Kinesin-like_fam | 2.58e-03 | 43 | 119 | 3 | IPR027640 | |
| Domain | - | 2.76e-03 | 44 | 119 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 2.76e-03 | 44 | 119 | 3 | PF00225 | |
| Domain | KISc | 2.76e-03 | 44 | 119 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 2.76e-03 | 44 | 119 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 2.76e-03 | 44 | 119 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 2.76e-03 | 44 | 119 | 3 | PS50067 | |
| Domain | BRLZ | 4.44e-03 | 52 | 119 | 3 | SM00338 | |
| Domain | BZIP | 4.69e-03 | 53 | 119 | 3 | PS50217 | |
| Domain | LRR_TYP | 5.53e-03 | 177 | 119 | 5 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 5.53e-03 | 177 | 119 | 5 | IPR003591 | |
| Domain | C1_1 | 5.75e-03 | 57 | 119 | 3 | PF00130 | |
| Domain | PH_dom-like | 5.96e-03 | 426 | 119 | 8 | IPR011993 | |
| Domain | ARM-type_fold | 6.04e-03 | 339 | 119 | 7 | IPR016024 | |
| Pathway | REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA | 2.06e-05 | 9 | 90 | 3 | M26946 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 4.59e-05 | 149 | 90 | 7 | M41805 | |
| Pubmed | A Conserved Role for Girdin in Basal Body Positioning and Ciliogenesis. | 2.72e-11 | 8 | 122 | 5 | 27623382 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CCHCR1 TANK ESYT1 SPTBN2 CEP290 PPP1R13B CEP164 IQGAP1 KIF7 MICALL1 CCDC88A HOOK3 CEP250 CEP295 MINDY4 ARHGEF2 FLOT1 TP53BP2 | 1.19e-09 | 853 | 122 | 18 | 28718761 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DDX19B KRT78 ESYT1 DZIP1 WDR59 MICALL1 ARFGEF3 FSIP2 VPS13D CCDC88A KCNQ5 CEP112 NAV1 MACF1 ARHGEF2 GOLGA4 TP53BP2 DOP1B | 1.38e-09 | 861 | 122 | 18 | 36931259 |
| Pubmed | SYNE1 SLC12A5 ARFGEF3 TENM3 GCC2 NAV1 MACF1 CHPF2 CROCC KIF17 VPS13B DOP1B | 2.29e-08 | 407 | 122 | 12 | 12693553 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 15731768 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 25660448 | ||
| Pubmed | ROCK2 TPR SYNE1 SPTBN2 NBEA IQGAP1 KIF7 SLC12A5 CCDC88A HOOK3 NAV1 CDK5RAP2 MACF1 ARHGEF2 GOLGA1 GOLGA4 TP53BP2 | 4.85e-08 | 963 | 122 | 17 | 28671696 | |
| Pubmed | 5.11e-08 | 146 | 122 | 8 | 21399614 | ||
| Pubmed | The trans-Golgi network GRIP-domain proteins form alpha-helical homodimers. | 1.68e-07 | 4 | 122 | 3 | 15654769 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SYNE1 PLEKHA6 MICALL1 CCDC88A HOOK3 SLC30A5 TENM3 PLEKHO2 SNX8 NAV1 SNU13 MACF1 NBR1 GOLGA4 | 2.52e-07 | 719 | 122 | 14 | 35337019 |
| Pubmed | 5.36e-07 | 19 | 122 | 4 | 24421332 | ||
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 12972563 | ||
| Pubmed | Cep44 functions in centrosome cohesion by stabilizing rootletin. | 8.36e-07 | 6 | 122 | 3 | 31974111 | |
| Pubmed | TNPO1 EXOSC10 ESYT1 SYNE1 SPTBN2 MRPL28 UFL1 FASTKD2 DZIP1 KIF7 MICALL1 CCDC88A CDK5RAP2 MACF1 FLOT1 NBR1 VPS13B GOLGA4 MAST3 | 1.08e-06 | 1487 | 122 | 19 | 33957083 | |
| Pubmed | 1.12e-06 | 151 | 122 | 7 | 17043677 | ||
| Pubmed | TPR SYNE1 SPTBN2 CEP290 PPP1R13B PLEKHA6 BLOC1S6 CCDC88A CEP250 NAV1 MACF1 | 1.23e-06 | 486 | 122 | 11 | 20936779 | |
| Pubmed | ROCK2 DOCK3 ANGPT1 SPTBN2 CEP290 PLEKHA6 WDR59 SMYD4 VPS13D MACF1 MAST3 | 1.42e-06 | 493 | 122 | 11 | 15368895 | |
| Pubmed | 1.59e-06 | 101 | 122 | 6 | 9872452 | ||
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 1.59e-06 | 101 | 122 | 6 | 24613305 | |
| Pubmed | Proteomic characterization of the human centrosome by protein correlation profiling. | 2.03e-06 | 26 | 122 | 4 | 14654843 | |
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 15706352 | ||
| Pubmed | ROCK2 ESYT1 PPP1R13B UFL1 DZIP1 PLEKHA6 CCDC88A SLC30A5 TENM3 MACF1 | 2.51e-06 | 421 | 122 | 10 | 36976175 | |
| Pubmed | USP34 DHX36 UFL1 FASTKD2 DZIP1 IQGAP1 MICALL1 ARHGAP4 CCDC88A CDK5RAP2 NBR1 | 2.79e-06 | 529 | 122 | 11 | 14621295 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 4.34e-06 | 120 | 122 | 6 | 31413325 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ESYT1 SPTBN2 PPP1R13B PLEKHA6 IQGAP1 MICALL1 TENM3 PLEKHO2 MACF1 FLOT1 TP53BP2 | 5.22e-06 | 565 | 122 | 11 | 25468996 |
| Pubmed | TNPO1 ROCK2 TPR ESYT1 UFL1 VPS13D SLC30A5 GCC2 CROCC VPS13B GOLGA4 | 5.48e-06 | 568 | 122 | 11 | 37774976 | |
| Pubmed | TNPO1 DMTF1 TPR CCHCR1 USP34 EXOSC10 SALL4 APOB BRD8 CEP112 CDK5RAP2 MACF1 P2RY14 CEP295 VPS13B | 6.34e-06 | 1084 | 122 | 15 | 11544199 | |
| Pubmed | 6.88e-06 | 130 | 122 | 6 | 12421765 | ||
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 7.90e-06 | 77 | 122 | 5 | 24927568 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 USP34 MAN2A2 ESYT1 MED14 ZNF236 IDUA CNTROB WDR59 MICALL1 PLEKHO2 SNX8 NAV1 MLLT1 ARHGEF2 | 7.97e-06 | 1105 | 122 | 15 | 35748872 |
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 1.17e-05 | 13 | 122 | 3 | 17920017 | |
| Pubmed | ESYT1 NBEA WDR59 PRKD3 ARFGEF3 VPS13D SLC30A5 VPS13B GOLGA4 DOP1B | 1.21e-05 | 504 | 122 | 10 | 34432599 | |
| Pubmed | Admission angiopoietin levels in children with septic shock. | 1.22e-05 | 2 | 122 | 2 | 18092380 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22642477 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 17273793 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 34643357 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15265687 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23785018 | ||
| Pubmed | Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension. | 1.22e-05 | 2 | 122 | 2 | 18382887 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15757645 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21778249 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23835996 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21113176 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23099117 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15047628 | ||
| Pubmed | The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors. | 1.22e-05 | 2 | 122 | 2 | 15213103 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19476937 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 31102187 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12858538 | ||
| Pubmed | Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma. | 1.22e-05 | 2 | 122 | 2 | 15094228 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 34726064 | ||
| Pubmed | Systemic Angiopoietin-1/2 Dysregulation in Pediatric Sepsis and Septic Shock. | 1.22e-05 | 2 | 122 | 2 | 30745813 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22949515 | ||
| Pubmed | Levels of angiopoietins 1 and 2 in induced sputum supernatant in patients with COPD. | 1.22e-05 | 2 | 122 | 2 | 22483377 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23915833 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23989887 | ||
| Pubmed | [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers]. | 1.22e-05 | 2 | 122 | 2 | 22169642 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 28027429 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 20072144 | ||
| Pubmed | Regulation of angiopoietin expression by bacterial lipopolysaccharide. | 1.22e-05 | 2 | 122 | 2 | 18310225 | |
| Pubmed | Increased levels of angiopoietins 1 and 2 in sputum supernatant in severe refractory asthma. | 1.22e-05 | 2 | 122 | 2 | 22229541 | |
| Pubmed | Angiopoietin-2, Angiopoietin-1 and subclinical cardiovascular disease in Chronic Kidney Disease. | 1.22e-05 | 2 | 122 | 2 | 27991547 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 20034025 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 27137842 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 27990590 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 25584916 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23302768 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 9545648 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19815705 | ||
| Pubmed | Angiopoietin-1/angiopoietin-2 ratio for prediction of preeclampsia. | 1.22e-05 | 2 | 122 | 2 | 19478794 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26595804 | ||
| Pubmed | Resveratrol induces apoptosis in breast cancer cells by E2F1-mediated up-regulation of ASPP1. | 1.22e-05 | 2 | 122 | 2 | 21479363 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23024612 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 36662891 | ||
| Pubmed | Vitreous levels of angiopoietin-1 and angiopoietin-2 in eyes with retinopathy of prematurity. | 1.22e-05 | 2 | 122 | 2 | 21168819 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12717391 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26367324 | ||
| Pubmed | Association of Angiopoietin Dysregulation in Placental Malaria with Adverse Birth Outcomes. | 1.22e-05 | 2 | 122 | 2 | 32399088 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 28734140 | ||
| Pubmed | A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. | 1.22e-05 | 2 | 122 | 2 | 12612904 | |
| Pubmed | Analysis of angiogenic markers in oral squamous cell carcinoma-gene and protein expression. | 1.22e-05 | 2 | 122 | 2 | 26044849 | |
| Pubmed | Dysregulation of angiopoietins is associated with placental malaria and low birth weight. | 1.22e-05 | 2 | 122 | 2 | 20208992 | |
| Pubmed | Angiopoietin-1 is an apoptosis survival factor for endothelial cells. | 1.22e-05 | 2 | 122 | 2 | 10218485 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26945868 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26283334 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24126820 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15823283 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16836957 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 32059166 | ||
| Pubmed | Angiopoietin 1 and angiopoietin 2 in follicular fluid of women undergoing a long protocol. | 1.22e-05 | 2 | 122 | 2 | 22000910 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16339073 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19300530 | ||
| Pubmed | Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C. | 1.22e-05 | 2 | 122 | 2 | 27956798 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15161644 | ||
| Pubmed | C-NAP1 and rootletin restrain DNA damage-induced centriole splitting and facilitate ciliogenesis. | 1.22e-05 | 2 | 122 | 2 | 23070519 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23734875 | ||
| Pubmed | Apoptosis stimulating protein of p53 (ASPP) 1 and ASPP2 m-RNA expression in oral cancer. | 1.22e-05 | 2 | 122 | 2 | 32987288 | |
| Pubmed | The angiopoietin 1/angiopoietin 2 balance as a prognostic marker in primary glioblastoma multiforme. | 1.22e-05 | 2 | 122 | 2 | 18991494 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12361603 | ||
| Pubmed | Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor. | 1.22e-05 | 2 | 122 | 2 | 29323190 | |
| Interaction | CEP135 interactions | CCHCR1 TANK CEP290 PPP1R13B CNTROB KIF20B CEP164 KIF7 CCDC88A CEP112 CEP250 NAV1 CDK5RAP2 CEP295 NBR1 TP53BP2 | 6.90e-12 | 272 | 120 | 16 | int:CEP135 |
| Interaction | NDC80 interactions | ROCK2 CCHCR1 KRT78 CEP290 PPP1R13B CNTROB CEP164 KIF7 BLOC1S6 GCC2 CEP250 NAV1 CDK5RAP2 CEP295 TP53BP2 | 5.51e-10 | 312 | 120 | 15 | int:NDC80 |
| Interaction | WHAMMP3 interactions | CCHCR1 ATF7 SYNE1 HOOK3 GCC2 CEP250 CDK5RAP2 CROCC GOLGA1 TP53BP2 | 2.36e-09 | 119 | 120 | 10 | int:WHAMMP3 |
| Interaction | PCM1 interactions | CCHCR1 CEP290 PPP1R13B CNTROB CEP164 KIF7 HOOK3 CEP112 GCC2 CEP250 NAV1 CDK5RAP2 CEP295 MINDY4 GOLGA1 TP53BP2 | 6.51e-09 | 434 | 120 | 16 | int:PCM1 |
| Interaction | APC interactions | IL24 TPR TRAF1 SYNE1 SPTBN2 PPP1R13B IQGAP1 KIF7 BLOC1S6 HOOK3 CEP250 NAV1 MACF1 FLOT1 GOLGA1 | 1.10e-08 | 389 | 120 | 15 | int:APC |
| Interaction | KRT19 interactions | CCHCR1 KRT78 CEP290 PPP1R13B CNTROB CEP164 KIF7 FANCG HOOK3 GCC2 CDK5RAP2 CEP295 TP53BP2 | 1.38e-08 | 282 | 120 | 13 | int:KRT19 |
| Interaction | NIN interactions | CCHCR1 CEP290 PPP1R13B CEP164 IQGAP1 KIF7 ARFGEF3 CEP250 SNU13 CEP295 ARHGEF2 FLOT1 TP53BP2 | 2.31e-07 | 359 | 120 | 13 | int:NIN |
| Interaction | RALBP1 interactions | CCHCR1 PPP1R13B CEP164 KIF7 HOOK3 CEP250 CDK5RAP2 CROCC GOLGA4 TP53BP2 | 3.04e-07 | 198 | 120 | 10 | int:RALBP1 |
| Interaction | SYNE3 interactions | CCHCR1 ESYT1 PPP1R13B UFL1 CNTROB CEP164 KIF7 KCNQ5 NAV1 CDK5RAP2 MACF1 CEP295 NBR1 TP53BP2 | 4.13e-07 | 444 | 120 | 14 | int:SYNE3 |
| Interaction | GOLGA1 interactions | 1.52e-06 | 183 | 120 | 9 | int:GOLGA1 | |
| Interaction | MAPRE1 interactions | DHX36 CEP290 PPP1R13B CCDC88A HOOK3 GCC2 CEP250 NAV1 SNU13 CDK5RAP2 MACF1 ARHGEF2 NBR1 GOLGA1 | 2.33e-06 | 514 | 120 | 14 | int:MAPRE1 |
| Interaction | CGN interactions | 3.58e-06 | 152 | 120 | 8 | int:CGN | |
| Interaction | TBK1 interactions | TPR SIKE1 TRAF1 TANK UFL1 APOB CNTROB BLOC1S6 TLR3 CDK5RAP2 RNF41 NBR1 | 5.11e-06 | 402 | 120 | 12 | int:TBK1 |
| Interaction | DTNBP1 interactions | 5.75e-06 | 162 | 120 | 8 | int:DTNBP1 | |
| Interaction | SSX2IP interactions | CCHCR1 CEP290 PPP1R13B KIF7 FANCG HOOK3 CEP250 CDK5RAP2 GOLGA1 TP53BP2 | 8.84e-06 | 288 | 120 | 10 | int:SSX2IP |
| Interaction | YWHAZ interactions | KRT78 ESYT1 SPTBN2 UFL1 DZIP1 WTAP MICALL1 FSIP2 VPS13D CCDC88A KCNQ5 PLEKHO2 CEP112 GCC2 NAV1 CDK5RAP2 MACF1 RNF41 ARHGEF2 CWF19L1 MAST3 TP53BP2 | 9.67e-06 | 1319 | 120 | 22 | int:YWHAZ |
| Interaction | PPP1R13B interactions | 1.06e-05 | 176 | 120 | 8 | int:PPP1R13B | |
| Interaction | LZTS2 interactions | TPR CEP290 PPP1R13B CNTROB CEP164 IQGAP1 KIF7 CCDC88A CEP112 CEP250 RNF41 CEP295 FLOT1 | 1.16e-05 | 512 | 120 | 13 | int:LZTS2 |
| Interaction | TRIM52 interactions | 1.49e-05 | 133 | 120 | 7 | int:TRIM52 | |
| Interaction | YWHAE interactions | ESYT1 UFL1 FASTKD2 WTAP IQGAP1 MICALL1 CCDC88A KCNQ5 PLEKHO2 CEP112 GCC2 CEP250 NAV1 MACF1 MINDY4 ARHGEF2 ARHGAP45 NBR1 CWF19L1 MAST3 TP53BP2 | 1.53e-05 | 1256 | 120 | 21 | int:YWHAE |
| Interaction | LURAP1 interactions | 1.81e-05 | 137 | 120 | 7 | int:LURAP1 | |
| Interaction | SEPTIN10 interactions | 2.49e-05 | 144 | 120 | 7 | int:SEPTIN10 | |
| Interaction | YWHAH interactions | KRT78 ESYT1 CEP290 DZIP1 IQGAP1 KIF7 MICALL1 ARFGEF3 VPS13D CCDC88A KCNQ5 CEP112 NAV1 MACF1 ARHGEF2 GOLGA4 MAST3 TP53BP2 DOP1B | 2.71e-05 | 1102 | 120 | 19 | int:YWHAH |
| Interaction | CEP89 interactions | 2.85e-05 | 147 | 120 | 7 | int:CEP89 | |
| Interaction | IRF3 interactions | 3.11e-05 | 149 | 120 | 7 | int:IRF3 | |
| Interaction | PXN interactions | CNTROB IQGAP1 KIF7 MICALL1 GCC2 CDK5RAP2 MACF1 ARHGEF2 GOLGA4 CREB3L2 | 3.17e-05 | 334 | 120 | 10 | int:PXN |
| Interaction | CCDC8 interactions | TNPO1 TPR KRT78 SPTBN2 CEP290 UFL1 APOB IQGAP1 KIF7 HOOK3 CEP250 MACF1 ARHGEF2 FLOT1 | 3.64e-05 | 656 | 120 | 14 | int:CCDC8 |
| Interaction | NUP62 interactions | 3.80e-05 | 273 | 120 | 9 | int:NUP62 | |
| Interaction | OFD1 interactions | TANK CEP290 CNTROB CEP164 IQGAP1 CDK5RAP2 CEP295 FLOT1 GOLGA1 TP53BP2 | 4.37e-05 | 347 | 120 | 10 | int:OFD1 |
| Interaction | GJA1 interactions | ROCK2 ESYT1 NBEA UFL1 APOB DZIP1 CCDC88A SLC30A5 GCC2 MACF1 NBR1 VPS13B GOLGA4 | 4.49e-05 | 583 | 120 | 13 | int:GJA1 |
| Interaction | SASS6 interactions | 4.70e-05 | 159 | 120 | 7 | int:SASS6 | |
| Interaction | STX4 interactions | ESYT1 SYNE1 PPP1R13B UFL1 CCDC88A KCNQ5 VAMP1 NAV1 NBR1 GOLGA4 TP53BP2 | 5.08e-05 | 428 | 120 | 11 | int:STX4 |
| Interaction | DISC1 interactions | CCHCR1 DHX36 SYNE1 CEP290 CEP164 KIF7 CCDC88A KCNQ5 NAV1 MACF1 FLOT1 | 5.19e-05 | 429 | 120 | 11 | int:DISC1 |
| Interaction | CCDC18 interactions | 5.32e-05 | 68 | 120 | 5 | int:CCDC18 | |
| Interaction | MLF1 interactions | 5.91e-05 | 113 | 120 | 6 | int:MLF1 | |
| Interaction | RPS6 interactions | ROCK2 DHX36 EXOSC10 PPP1R13B MRPL28 UFL1 APOB USP9Y ZC3H3 IQGAP1 GVINP1 CEP250 SNU13 MINDY4 ARHGEF2 TP53BP2 | 6.20e-05 | 874 | 120 | 16 | int:RPS6 |
| Interaction | KRT13 interactions | 6.84e-05 | 116 | 120 | 6 | int:KRT13 | |
| Interaction | BORCS6 interactions | 7.18e-05 | 170 | 120 | 7 | int:BORCS6 | |
| Interaction | PEX14 interactions | 8.81e-05 | 237 | 120 | 8 | int:PEX14 | |
| Interaction | DUSP16 interactions | 8.81e-05 | 237 | 120 | 8 | int:DUSP16 | |
| Interaction | TNIK interactions | TPR SIKE1 SYNE1 SPTBN2 PPP1R13B NBEA KIF7 MACF1 ARHGEF2 GOLGA4 | 9.51e-05 | 381 | 120 | 10 | int:TNIK |
| Interaction | CEP63 interactions | 9.92e-05 | 179 | 120 | 7 | int:CEP63 | |
| Interaction | LAMTOR1 interactions | ROCK2 SPTBN2 NBEA WDR59 IQGAP1 MICALL1 PRKD3 ARFGEF3 BLOC1S6 CCDC88A GCC2 FLOT1 VPS13B GOLGA4 | 1.01e-04 | 722 | 120 | 14 | int:LAMTOR1 |
| Interaction | YWHAB interactions | ESYT1 DZIP1 IQGAP1 MICALL1 VPS13D CCDC88A HOOK3 KCNQ5 PLEKHO2 CEP112 GCC2 NAV1 MACF1 ARHGEF2 CWF19L1 MAST3 TP53BP2 | 1.06e-04 | 1014 | 120 | 17 | int:YWHAB |
| Interaction | SYCE1 interactions | 1.13e-04 | 127 | 120 | 6 | int:SYCE1 | |
| Interaction | TPM3 interactions | CCHCR1 DHX36 UFL1 WTAP IQGAP1 BLOC1S6 HOOK3 ARHGEF2 CROCC GOLGA4 | 1.15e-04 | 390 | 120 | 10 | int:TPM3 |
| Interaction | YWHAG interactions | DDX19B ESYT1 DZIP1 IQGAP1 KIF7 MICALL1 VPS13D CCDC88A KCNQ5 CEP112 GCC2 CEP250 NAV1 MACF1 MAFB ARHGEF2 NBR1 MAST3 TP53BP2 | 1.43e-04 | 1248 | 120 | 19 | int:YWHAG |
| Interaction | CEP43 interactions | 1.44e-04 | 190 | 120 | 7 | int:CEP43 | |
| Interaction | RAB2A interactions | ROCK2 SPTBN2 CEP290 NBEA CNTROB IQGAP1 ARFGEF3 CCDC88A SLC30A5 GCC2 FLOT1 GOLGA4 | 1.46e-04 | 567 | 120 | 12 | int:RAB2A |
| Interaction | SQSTM1 interactions | TNPO1 TRAF1 CEP290 PPP1R13B FASTKD2 CEP164 IQGAP1 KIF7 ARFGEF3 CEP112 CEP250 TLR3 NAV1 CDK5RAP2 CROCC FLOT1 NBR1 GOLGA1 TP53BP2 | 1.57e-04 | 1257 | 120 | 19 | int:SQSTM1 |
| Interaction | CDC5L interactions | TNPO1 ROCK2 DDX19B TPR EXOSC10 SYNE1 PPP1R13B UFL1 IQGAP1 BRD8 MACF1 MAFB ARHGEF2 CWF19L1 TP53BP2 | 1.71e-04 | 855 | 120 | 15 | int:CDC5L |
| Interaction | DCTN1 interactions | TPR SPTBN2 CEP290 MED14 UFL1 KIF7 CCDC88A HOOK3 NAV1 MACF1 ARHGEF2 | 1.90e-04 | 497 | 120 | 11 | int:DCTN1 |
| Interaction | PIBF1 interactions | 1.97e-04 | 200 | 120 | 7 | int:PIBF1 | |
| Interaction | PHF21A interactions | 2.15e-04 | 343 | 120 | 9 | int:PHF21A | |
| Interaction | EXOC1 interactions | 2.16e-04 | 143 | 120 | 6 | int:EXOC1 | |
| Interaction | RAB9A interactions | TANK ESYT1 NBEA UFL1 WDR59 MICALL1 ARFGEF3 VPS13D GCC2 VPS13B GOLGA4 DOP1B | 2.28e-04 | 595 | 120 | 12 | int:RAB9A |
| Interaction | FPR1 interactions | 2.51e-04 | 147 | 120 | 6 | int:FPR1 | |
| Interaction | RHOA interactions | ROCK2 PLEKHG4 ESYT1 SPTBN2 UFL1 FASTKD2 IQGAP1 MICALL1 VPS13D CCDC88A SLC30A5 TENM3 MACF1 ARHGEF2 FLOT1 NBR1 VPS13B GOLGA4 | 2.58e-04 | 1199 | 120 | 18 | int:RHOA |
| Interaction | LAMP2 interactions | ROCK2 DDX19B ESYT1 SPTBN2 NBEA WDR59 ARFGEF3 SLC30A5 KCNQ5 GCC2 GOLGA4 DOP1B | 2.81e-04 | 609 | 120 | 12 | int:LAMP2 |
| Interaction | CD40 interactions | 3.11e-04 | 153 | 120 | 6 | int:CD40 | |
| Interaction | E2F2 interactions | 3.23e-04 | 55 | 120 | 4 | int:E2F2 | |
| Interaction | RAC3 interactions | ROCK2 PLEKHG4 ESYT1 SPTBN2 IQGAP1 MICALL1 CCDC88A SLC30A5 TENM3 MACF1 FLOT1 GOLGA4 | 3.26e-04 | 619 | 120 | 12 | int:RAC3 |
| Interaction | FHIP2A interactions | 3.46e-04 | 56 | 120 | 4 | int:FHIP2A | |
| Interaction | P2RY14 interactions | 3.48e-04 | 5 | 120 | 2 | int:P2RY14 | |
| Interaction | ZFPL1 interactions | SPTBN2 PPP1R13B NBEA MICALL1 VPS13D CCDC88A SLC30A5 GCC2 VPS13B GOLGA4 | 3.51e-04 | 448 | 120 | 10 | int:ZFPL1 |
| Interaction | SCGB2A2 interactions | 3.82e-04 | 223 | 120 | 7 | int:SCGB2A2 | |
| Interaction | GJD3 interactions | ESYT1 SYNE1 SPTBN2 UFL1 CCDC88A SLC30A5 GCC2 NBR1 VPS13B GOLGA4 | 3.89e-04 | 454 | 120 | 10 | int:GJD3 |
| Interaction | CEP128 interactions | 4.09e-04 | 297 | 120 | 8 | int:CEP128 | |
| Interaction | IKBKE interactions | 4.32e-04 | 106 | 120 | 5 | int:IKBKE | |
| Interaction | TICAM1 interactions | 4.51e-04 | 60 | 120 | 4 | int:TICAM1 | |
| Interaction | MAPRE3 interactions | 4.59e-04 | 230 | 120 | 7 | int:MAPRE3 | |
| Interaction | GSK3A interactions | TANK LRRC37A2 CNTROB PRKD3 ARFGEF3 VPS13D CCDC88A MACF1 NBR1 TP53BP2 | 4.62e-04 | 464 | 120 | 10 | int:GSK3A |
| Interaction | CEP57 interactions | 4.65e-04 | 165 | 120 | 6 | int:CEP57 | |
| Interaction | PLEKHA5 interactions | 4.71e-04 | 231 | 120 | 7 | int:PLEKHA5 | |
| Interaction | SYNGAP1 interactions | 5.09e-04 | 307 | 120 | 8 | int:SYNGAP1 | |
| Interaction | ZNF252P-AS1 interactions | 5.43e-04 | 27 | 120 | 3 | int:ZNF252P-AS1 | |
| Interaction | AMOT interactions | 5.66e-04 | 312 | 120 | 8 | int:AMOT | |
| Interaction | NUP155 interactions | TNPO1 DDX19B ESYT1 UFL1 KIF7 VPS13D SLC30A5 GCC2 VPS13B GOLGA4 | 5.72e-04 | 477 | 120 | 10 | int:NUP155 |
| Interaction | CTAG1B interactions | 5.79e-04 | 113 | 120 | 5 | int:CTAG1B | |
| Interaction | KRT38 interactions | 5.80e-04 | 172 | 120 | 6 | int:KRT38 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.26e-05 | 206 | 79 | 7 | 682 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.06e-03 | 46 | 79 | 3 | 622 | |
| GeneFamily | Basic leucine zipper proteins | 1.28e-03 | 49 | 79 | 3 | 506 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 4.41e-06 | 199 | 122 | 8 | M5893 | |
| Coexpression | GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN | 4.57e-06 | 200 | 122 | 8 | M6938 | |
| Coexpression | GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN | 8.02e-06 | 154 | 122 | 7 | M6824 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DMTF1 TPR USP34 TRAF1 TANK MAN2A2 ESYT1 SYNE1 IQGAP1 PRKD3 CREBRF ARHGAP4 CCDC88A GVINP1 PLEKHO2 VAMP1 MACF1 ARHGAP45 VPS13B MAST3 | 1.81e-05 | 1492 | 122 | 20 | M40023 |
| Coexpression | GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_UP | 4.19e-05 | 199 | 122 | 7 | M4148 | |
| Coexpression | GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN | 4.19e-05 | 199 | 122 | 7 | M6211 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | 4.33e-05 | 200 | 122 | 7 | M8306 | |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP | 4.49e-05 | 137 | 122 | 6 | M34024 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_UP | 5.71e-05 | 143 | 122 | 6 | MM788 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_UP | 5.71e-05 | 143 | 122 | 6 | M16927 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TNPO1 DHX36 CEP290 UFL1 DZIP1 KIF20B CCDC88A SLC30A5 CEP112 GCC2 CDK5RAP2 GOLGA4 | 5.78e-05 | 656 | 122 | 12 | M18979 |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 9.21e-05 | 97 | 122 | 5 | M14698 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN | 1.06e-04 | 160 | 122 | 6 | M8664 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | ROCK2 TPR MAN2A2 ANGPT1 SYNE1 CEP290 KIF20B GCC2 CDK5RAP2 MACF1 MAFB CEP295 ARHGEF2 | 1.15e-06 | 432 | 121 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | ROCK2 TPR MAN2A2 ENOX1 ANGPT1 SYNE1 CEP290 SALL4 KIF20B WTAP KIF7 GCC2 NAV1 CDK5RAP2 MACF1 MAFB CEP295 ARHGEF2 KIF17 | 3.20e-06 | 989 | 121 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.70e-05 | 166 | 121 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 7.43e-05 | 311 | 121 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 9.63e-05 | 186 | 121 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 1.08e-04 | 255 | 121 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | ROCK2 MAN2A2 ENOX1 ANGPT1 SYNE1 CEP290 SALL4 KIF20B GCC2 MAFB KIF17 | 1.19e-04 | 492 | 121 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.73e-08 | 186 | 122 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-07 | 184 | 122 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.21e-06 | 197 | 122 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.30e-06 | 199 | 122 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.38e-06 | 148 | 122 | 6 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-06 | 168 | 122 | 6 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-06 | 168 | 122 | 6 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.13e-06 | 97 | 122 | 5 | f3c3fb260954f594a9ab8e1ac9a01115767cbc7a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.49e-06 | 170 | 122 | 6 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 180 | 122 | 6 | b28363626f4d2a552abde3434cc1df2e2121aba5 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 180 | 122 | 6 | 67b062f2ef7e20f392e00c646f4985c415d40de9 | |
| ToppCell | Healthy-multiplets|World / disease group, cell group and cell class | 1.07e-05 | 181 | 122 | 6 | f8dbac3cd500cc8d80853312b00d124c27b8fd85 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 182 | 122 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 185 | 122 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.73e-05 | 197 | 122 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.78e-05 | 198 | 122 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.78e-05 | 198 | 122 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.83e-05 | 199 | 122 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 4.06e-05 | 139 | 122 | 5 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.61e-05 | 154 | 122 | 5 | 5967a0a33456d5930fc492a700ebb015ac050abb | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.82e-05 | 155 | 122 | 5 | fab281db4c275d51240b122be78713c839ba5a95 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 7.03e-05 | 156 | 122 | 5 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.92e-05 | 160 | 122 | 5 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.16e-05 | 161 | 122 | 5 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 8.40e-05 | 162 | 122 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.64e-05 | 163 | 122 | 5 | f558ad9569e5137e62a601ba4f073e69ed8f8650 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.16e-05 | 165 | 122 | 5 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.16e-05 | 165 | 122 | 5 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | Dendritic_Cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 9.42e-05 | 166 | 122 | 5 | fbeb74b98b58085de323f744b18d4a8f7b22d5d4 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 170 | 122 | 5 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 170 | 122 | 5 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.08e-04 | 171 | 122 | 5 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 175 | 122 | 5 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 175 | 122 | 5 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 176 | 122 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte-Alox5+_lymphocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-04 | 177 | 122 | 5 | b7cfa3776f58377e35830780650d236b5cceecee | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-04 | 177 | 122 | 5 | 1730e640986e50943bd781b7d949bcc5b7c12dde | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 177 | 122 | 5 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 177 | 122 | 5 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 177 | 122 | 5 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| ToppCell | ICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, Lineage and Cell Type | 1.27e-04 | 177 | 122 | 5 | 33cd2c183ee8b597012efcbcae72131ac6beaf4e | |
| ToppCell | ASK454-Endothelial-Lymphatic|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.34e-04 | 179 | 122 | 5 | fd84a79f76a01c0377dff5b20016b004d369f96f | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 181 | 122 | 5 | 57f0cc749ae8b6a3d77e2af31f9a6e4739c57049 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 181 | 122 | 5 | d01b35cc2fc57991a35be6a06cb7351fbabd9a11 | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.49e-04 | 183 | 122 | 5 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | Control-APC-like|Control / group, cell type (main and fine annotations) | 1.49e-04 | 183 | 122 | 5 | c313ac72cc9fa1583456d452393f61f0a4ca33a8 | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-04 | 185 | 122 | 5 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.60e-04 | 186 | 122 | 5 | 0dce13e15c3bf32610bf2dad31253b52a39cff87 | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 1.64e-04 | 187 | 122 | 5 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-04 | 187 | 122 | 5 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 1.69e-04 | 188 | 122 | 5 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 190 | 122 | 5 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 190 | 122 | 5 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-04 | 190 | 122 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 191 | 122 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Dendritic_Cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.81e-04 | 191 | 122 | 5 | b51c8ff1279581088557bb36760c70209c77148c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 191 | 122 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 191 | 122 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.90e-04 | 193 | 122 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.90e-04 | 193 | 122 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.90e-04 | 193 | 122 | 5 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | Dendritic_Cells|World / lung cells shred on cell class, cell subclass, sample id | 1.90e-04 | 193 | 122 | 5 | 7792eb6e247af2d7a8f80476f37dcd880922d625 | |
| ToppCell | Control-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 1.95e-04 | 194 | 122 | 5 | 5f95a5a35f73222dbe2ca52cc580f4774f641403 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 194 | 122 | 5 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 194 | 122 | 5 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-04 | 194 | 122 | 5 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 1.95e-04 | 194 | 122 | 5 | 768271ae45ff9f6aa3cd9b0ed15fa3caaa68a7b0 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 194 | 122 | 5 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-04 | 194 | 122 | 5 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.00e-04 | 195 | 122 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.00e-04 | 195 | 122 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 195 | 122 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.00e-04 | 195 | 122 | 5 | 67b05a0cd2ca9924eca81a92cc6330eecb9d963c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 195 | 122 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-04 | 196 | 122 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COVID-mDC2|COVID / Condition, Cell_class and T cell subcluster | 2.05e-04 | 196 | 122 | 5 | bb13926bb664be917017edb0ce7f184abe31744b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.05e-04 | 196 | 122 | 5 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | COVID-mDC2-|COVID / Condition, Cell_class and T cell subcluster | 2.05e-04 | 196 | 122 | 5 | 6d02a4c5c19be7e036150cf945585cf5a773bc87 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-04 | 196 | 122 | 5 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-04 | 197 | 122 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.09e-04 | 197 | 122 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | mild-pDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.09e-04 | 197 | 122 | 5 | 15230a54fa5903dd728de1a0ad633bd2d2c7a04d | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.09e-04 | 197 | 122 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.14e-04 | 198 | 122 | 5 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-04 | 198 | 122 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-04 | 198 | 122 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-04 | 198 | 122 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-04 | 198 | 122 | 5 | c64238379798ae6b292cc1914d60548c88e652de | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.19e-04 | 199 | 122 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.19e-04 | 199 | 122 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.19e-04 | 199 | 122 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.25e-04 | 200 | 122 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.25e-04 | 200 | 122 | 5 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.25e-04 | 200 | 122 | 5 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.25e-04 | 200 | 122 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 2.25e-04 | 200 | 122 | 5 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.25e-04 | 200 | 122 | 5 | 49ad6e2337886367fbfa2a7c7366687b701ddf39 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 2.25e-04 | 200 | 122 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.25e-04 | 200 | 122 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.01e-05 | 194 | 122 | 8 | 4134_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A | 1.05e-05 | 195 | 122 | 8 | 2264_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 1.05e-05 | 195 | 122 | 8 | 7048_UP | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 1.09e-05 | 196 | 122 | 8 | 1178_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; HL60; HG-U133A | 1.09e-05 | 196 | 122 | 8 | 1586_UP | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.17e-05 | 198 | 122 | 8 | 5345_DN | |
| Drug | Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.22e-05 | 199 | 122 | 8 | 3563_DN | |
| Drug | diethyl acetylenedicarboxylate | 2.85e-05 | 2 | 122 | 2 | CID000069803 | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; HL60; HT_HG-U133A | 5.74e-05 | 182 | 122 | 7 | 1280_UP | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; HL60; HG-U133A | 7.28e-05 | 189 | 122 | 7 | 1622_UP | |
| Drug | Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 8.04e-05 | 192 | 122 | 7 | 2873_DN | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A | 8.04e-05 | 192 | 122 | 7 | 4496_DN | |
| Drug | bis(dicyclohexylphosphino)methane | 8.51e-05 | 3 | 122 | 2 | CID000618458 | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 8.86e-05 | 195 | 122 | 7 | 3942_DN | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 8.86e-05 | 195 | 122 | 7 | 2278_DN | |
| Drug | Condelphine [7633-69-4]; Down 200; 8.8uM; HL60; HT_HG-U133A | 9.15e-05 | 196 | 122 | 7 | 2976_DN | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 9.15e-05 | 196 | 122 | 7 | 2889_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HG-U133A | 9.15e-05 | 196 | 122 | 7 | 1961_UP | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 5436_DN | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HG-U133A | 9.44e-05 | 197 | 122 | 7 | 1941_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 3277_DN | |
| Drug | Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 2623_UP | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 5871_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 5595_UP | |
| Drug | Amoxapine [14028-44-5]; Down 200; 12.8uM; HL60; HG-U133A | 9.75e-05 | 198 | 122 | 7 | 2013_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 7366_DN | |
| Drug | Chenodiol [474-25-9]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 7433_UP | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 4390_DN | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; HL60; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 6148_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 7298_UP | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; PC3; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 7267_DN | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; PC3; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 7374_UP | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; HL60; HT_HG-U133A | 1.04e-04 | 200 | 122 | 7 | 2141_UP | |
| Disease | Duane Retraction Syndrome, Type 2 | 4.83e-05 | 3 | 119 | 2 | C0751083 | |
| Disease | Duane Retraction Syndrome, Type 3 | 4.83e-05 | 3 | 119 | 2 | C0751084 | |
| Disease | Type 1 Duane Retraction Syndrome | 4.83e-05 | 3 | 119 | 2 | C0994516 | |
| Disease | Duane retraction syndrome (is_implicated_in) | 4.83e-05 | 3 | 119 | 2 | DOID:12557 (is_implicated_in) | |
| Disease | Okihiro Syndrome | 4.83e-05 | 3 | 119 | 2 | C1623209 | |
| Disease | gastric ulcer (biomarker_via_orthology) | 8.07e-05 | 21 | 119 | 3 | DOID:10808 (biomarker_via_orthology) | |
| Disease | Duane Retraction Syndrome | 1.60e-04 | 5 | 119 | 2 | C0013261 | |
| Disease | post-traumatic stress disorder symptom measurement | 3.45e-04 | 82 | 119 | 4 | EFO_0008535 | |
| Disease | Spinocerebellar Ataxia Type 4 | 3.81e-04 | 35 | 119 | 3 | C0752122 | |
| Disease | Malignant neoplasm of breast | IL24 TANK SYNE1 LRRC37A2 MED14 E2F1 NUDT17 MICALL1 HOOK3 LRRC37A MACF1 VPS13B TP53BP2 | 4.04e-04 | 1074 | 119 | 13 | C0006142 |
| Disease | Colorectal Carcinoma | SYNE1 SPTBN2 APOB MFN1 SLC12A5 FANCG KCNQ5 SNX8 P2RY14 SPAG17 | 5.66e-04 | 702 | 119 | 10 | C0009402 |
| Disease | polymeric immunoglobulin receptor measurement | 7.11e-04 | 10 | 119 | 2 | EFO_0008267 | |
| Disease | endometrial adenocarcinoma (is_marker_for) | 8.66e-04 | 11 | 119 | 2 | DOID:2870 (is_marker_for) | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 1.04e-03 | 12 | 119 | 2 | C0403553 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.04e-03 | 12 | 119 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Ciliopathies | 1.04e-03 | 110 | 119 | 4 | C4277690 | |
| Disease | mammographic density measurement | 1.09e-03 | 50 | 119 | 3 | EFO_0005941 | |
| Disease | bone fracture | 1.12e-03 | 112 | 119 | 4 | EFO_0003931 | |
| Disease | Polydactyly | 1.31e-03 | 117 | 119 | 4 | C0152427 | |
| Disease | Mammary Carcinoma, Human | 1.33e-03 | 525 | 119 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.33e-03 | 525 | 119 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 1.36e-03 | 527 | 119 | 8 | C1458155 | |
| Disease | isoleucine measurement | 1.52e-03 | 56 | 119 | 3 | EFO_0009793 | |
| Disease | Breast Carcinoma | 1.55e-03 | 538 | 119 | 8 | C0678222 | |
| Disease | cortical thickness | ANGPT1 SPTBN2 IDUA KIF20B MICALL1 VPS13D CCDC88A CEP112 NAV1 CDK5RAP2 MACF1 CFAP57 | 1.82e-03 | 1113 | 119 | 12 | EFO_0004840 |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 2.11e-03 | 17 | 119 | 2 | C2936862 | |
| Disease | refractive error | 2.12e-03 | 326 | 119 | 6 | MONDO_0004892 | |
| Disease | histidine measurement | 2.43e-03 | 66 | 119 | 3 | EFO_0009769 | |
| Disease | alkaline phosphatase measurement | USP34 ATF7 APOB SLC12A5 SLC30A5 GCC2 MACF1 MAFB CHPF2 KIF17 CREB3L2 | 2.72e-03 | 1015 | 119 | 11 | EFO_0004533 |
| Disease | Familial aplasia of the vermis | 2.92e-03 | 20 | 119 | 2 | cv:C0431399 | |
| Disease | progranulin measurement | 3.53e-03 | 22 | 119 | 2 | EFO_0004625 | |
| Disease | otitis media (implicated_via_orthology) | 3.53e-03 | 22 | 119 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | nephrosis (biomarker_via_orthology) | 3.53e-03 | 22 | 119 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | platelet component distribution width | 3.56e-03 | 755 | 119 | 9 | EFO_0007984 | |
| Disease | unipolar depression, bipolar disorder | 3.73e-03 | 156 | 119 | 4 | EFO_0003761, MONDO_0004985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELEEVLQVNSLIQTQ | 776 | Q9BSJ8 | |
| QQINSTIVDLRLNEN | 56 | P0C7U0 | |
| QRDVLEQIQQFLATQ | 801 | Q9H0E9 | |
| VINSIKQEIVNRVQN | 566 | Q8IUR6 | |
| VSLQNLIVRDIANQE | 521 | Q92974 | |
| EQVNISQFSQLIEIL | 626 | Q7Z2Y8 | |
| EAQVLNQTTRLELQL | 146 | O15123 | |
| ELINVNSQRKQQLVE | 736 | Q8N8E3 | |
| QVLNQTSRLEIQLLE | 151 | Q15389 | |
| NIQLSNEVTLLRNEV | 371 | P17544 | |
| QVQQLEAQVQLLVGR | 401 | Q569K6 | |
| SNRRENSVQVVIQVL | 2486 | Q9H251 | |
| TQIQILQNEQLDEIS | 106 | Q9Y222 | |
| QEVQTAILRVDQLSQ | 226 | Q96KQ4 | |
| QIEAQQQLLATKEQR | 141 | Q13625 | |
| VQEEVKLRQQLLSQN | 1536 | Q96SN8 | |
| VITLIRSNQQLENDL | 896 | P46940 | |
| ALLTNVDQIVQETQR | 701 | Q96NI6 | |
| NALVLQTQQEIIENL | 466 | Q8IWA4 | |
| QLIQLINVDEVNQIV | 56 | P02708 | |
| TALRQIQEVIRQSDQ | 486 | Q92619 | |
| TQLIQQVEQLKQEVS | 271 | Q9Y5Q3 | |
| QELQALIQQLSIDLQ | 266 | Q92805 | |
| DQFEIQLTQQLQSLI | 1471 | A6NM11 | |
| DQFEIQLTQQLQSLI | 1471 | A6NMS7 | |
| LLVISQESQQQLQAR | 186 | P0C025 | |
| AQLRQLTEEQNTLNI | 1276 | Q13439 | |
| VTNERDQALQLQVLN | 886 | Q13201 | |
| ESINLQQEALQRIIS | 31 | Q9BXM9 | |
| IQRLRDQIQEQEQVT | 1211 | Q96MR6 | |
| LDSNVLVQRNNLEIV | 236 | Q9Y3R5 | |
| SVQNLIRSTEELNIQ | 831 | Q9NR82 | |
| SLIVNEEVQNLISNI | 881 | Q5CZC0 | |
| FITQAQEQQIELLEI | 436 | Q69YN2 | |
| QQVLELEIQLANITV | 346 | P0DPD6 | |
| AQILALQRQTVSLQE | 1081 | Q3V6T2 | |
| EQRVQVQVVERAQQV | 251 | O75955 | |
| LRQQQQQLLSAIIEA | 681 | Q9UGI6 | |
| TQNQRIKELINIIDQ | 761 | Q96Q89 | |
| AQQLLTLQNQVARLE | 486 | Q2M1P5 | |
| VVRTQETQEIRTLNN | 106 | Q8N1N4 | |
| LSQVQRLITNVESQL | 311 | O76009 | |
| QESQLRNEVAILQNL | 616 | O94806 | |
| QLKQQIQSIQQSIER | 111 | P55769 | |
| QELVTLIEQRNAIIN | 786 | Q8N3F8 | |
| IQRSLERVLETQEQQ | 96 | O15287 | |
| QLQTQLEQLQEETFR | 246 | Q86VS8 | |
| QEILQVEQQLANITV | 311 | O95672 | |
| RLEQDQTTAQLQVQK | 5701 | Q9UPN3 | |
| QRIIQQETLQLINSN | 1221 | O60244 | |
| AEQAISVRQQVVLEN | 761 | Q01780 | |
| QTIIVVLENVQRNLK | 2086 | P04114 | |
| QRQIQQLEAQVVVLE | 1921 | Q5TZA2 | |
| LTQDLRQLQESEQQL | 206 | Q01094 | |
| IQVVENKNQELRSLI | 1511 | Q8IZD9 | |
| IARRQVEILNAQQQS | 1161 | O15078 | |
| REEQIVQLLNSVQAK | 91 | Q9H2U1 | |
| TLQLRQRQENTIIEN | 171 | Q5TH69 | |
| LQLVLEEQVLALQQQ | 16 | Q9BV73 | |
| LLLSQREQEIVVLQQ | 1771 | Q9BV73 | |
| IRSNLVDNTNQVEVL | 66 | Q9UMR2 | |
| TRLENQNLLIQVEEV | 871 | Q8IWJ2 | |
| ITSARLLQQEVLQNV | 86 | Q13007 | |
| ALSQQAEVIVRQLQE | 86 | Q8TD31 | |
| QNQVVLLDTLEQEIS | 76 | Q9UL45 | |
| SILEQEKVVAQQIRQ | 271 | P35475 | |
| QISVLQNRIEQLEQL | 46 | P49641 | |
| RNQIQQVFVERDILT | 406 | O60307 | |
| ERNVLQQIVNLIEET | 511 | Q03111 | |
| TILVLQQQLKETRQQ | 221 | Q15007 | |
| ENLTILQEQSQIQRV | 1161 | Q9C0D2 | |
| VVQQQQTRIAELEKT | 141 | Q9H4P4 | |
| LQQIQLTEQIRIQVN | 226 | Q9UJQ4 | |
| VLTVALVNQDRENNI | 541 | Q8TC92 | |
| SLQTRVLELQQQLAV | 206 | Q8N137 | |
| EVLENTNRTLLQQLQ | 341 | Q70SY1 | |
| QLLVLVRVDQDQNVV | 696 | Q9H2X9 | |
| VDQQQVLARLQLLEQ | 736 | Q9P2E2 | |
| TVQNVLDLRQNLEET | 261 | Q8NEY1 | |
| VIEQLQTTQTIQDIL | 136 | O75529 | |
| VQTERQRIQTEFDQL | 176 | Q9BYJ4 | |
| NRRLQQTQAQVEEVV | 31 | P23763 | |
| VSRLQDLQQQVRVAQ | 651 | Q8IYR2 | |
| QLESRIVEQENAIQT | 371 | Q9Y5X2 | |
| LQLIQALQNEVVSQA | 1696 | Q8NF91 | |
| EQQLAAQLVTLQNEL | 171 | P0C7N4 | |
| ILQVVTELLQLNNND | 946 | Q14596 | |
| QSNQRIQALELVQTL | 441 | Q58EX7 | |
| QNTILVQTLLRVTQE | 246 | Q9NYY8 | |
| RQITDLVDQSIQINA | 2666 | Q8NFP9 | |
| ILLSQENTQIRDLQQ | 71 | Q9BRV8 | |
| IREQQEQLSLQQTII | 41 | Q92844 | |
| NIILTNQSVREVTQI | 156 | Q15391 | |
| VTEQRQLEVLCSQVQ | 76 | P0DJH9 | |
| QEQNELIITQRQQIK | 426 | Q86YF9 | |
| LQGRVNQLVQTLIVQ | 676 | P98171 | |
| QDILQQINEINTLVG | 71 | Q6Q759 | |
| LESQVDLLQAQSQQL | 1011 | Q9UPV0 | |
| SEIEQLQAQIRNLTV | 331 | Q9P2E5 | |
| SLQNQLINIRVELSQ | 591 | Q9Y2H5 | |
| LERQVQLSQGQNVVI | 111 | Q8IXZ2 | |
| VQQAIEQNLDSIILV | 836 | O15455 | |
| LANQQEQIRLTIDTT | 706 | Q4G0A6 | |
| IEQTIVTLNDRQLAN | 321 | O15020 | |
| SQELLAQLNRAVQVV | 91 | P41226 | |
| ARNLQEQTVQLQSEL | 1511 | P12270 | |
| QVEQQVKELQNRLSQ | 861 | O94964 | |
| QISTEKVNQLQRQLD | 551 | O75116 | |
| SLEQRVVELQQTLAQ | 231 | Q13077 | |
| DNNVVLQITENRQVR | 1361 | Q9P273 | |
| VAELIQQLQQQALSE | 231 | Q13084 | |
| IQQNNILSIVLQDSL | 391 | O00507 | |
| TIQRTVQQKLEQLNQ | 36 | Q92973 | |
| NQGNQIVSLIIIQEE | 211 | Q8NAM6 | |
| LQQEFSLINVQIRNV | 391 | Q6PJI9 | |
| RVVNNVNIVINNLIL | 146 | Q7Z7G8 | |
| QVTSDVLEQRIVQQV | 696 | Q8TAD4 | |
| QLSITVGINQDILQQ | 381 | Q9UL36 | |
| QAVEQLRQATQVLQE | 446 | Q8TD55 | |
| LINLVIAQVQVLRDQ | 66 | Q70CQ2 | |
| QSINENLVLQSIELE | 661 | Q9BXT5 | |
| TDLQILSTQVEQRLN | 1021 | Q6ZQQ6 | |
| RVNIVDLQQVINVDL | 76 | O94874 | |
| QVISLQVNNLDIILN | 1101 | Q5THJ4 |